Journal of Cachexia Sarcopenia and Muscle

Papers
(The H4-Index of Journal of Cachexia Sarcopenia and Muscle is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis356
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021297
Osteosarcopenia: epidemiology, diagnosis, and treatment—facts and numbers195
Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults190
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia170
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review140
COVID‐19: a major cause of cachexia and sarcopenia?137
Understanding the gut microbiota and sarcopenia: a systematic review115
Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19112
Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysis103
The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.93
Effects of statins on mitochondrial pathways88
Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers85
Mouse models of sarcopenia: classification and evaluation78
Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis77
Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients75
Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study72
Muscle wasting as an independent predictor of survival in patients with chronic heart failure71
Muscular weakness and muscle wasting in the critically ill69
Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis68
Efficacy of multidomain interventions to improve physical frailty, depression and cognition: data from cluster‐randomized controlled trials67
Associations of low handgrip strength with cancer mortality: a multicentre observational study66
Systematic review and meta‐analysis of protein intake to support muscle mass and function in healthy adults61
Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis60
Inhibition of the NLRP3/IL‐1β axis protects against sepsis‐induced cardiomyopathy60
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia59
Low skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta‐analysis59
Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China57
Sarcopenia and peripheral arterial disease: a systematic review57
Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality56
Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting56
Roles of nutrition in muscle health of community‐dwelling older adults: evidence‐based expert consensus from Asian Working Group for Sarcopenia54
Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study54
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients54
Prevalence of protein intake below recommended in community‐dwelling older adults: a meta‐analysis across cohorts from the PROMISS consortium54
Gut microbes and muscle function: can probiotics make our muscles stronger?53
Improving rehabilitation in sarcopenia: a randomized‐controlled trial utilizing a muscle‐targeted food for special medical purposes51
How gait influences frailty models and health‐related outcomes in clinical‐based and population‐based studies: a systematic review51
Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID‐19: a prospective observational study51
Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta‐analysis51
Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study51
Normative values of muscle strength across ages in a ‘real world’ population: results from the longevity check‐up 7+ project50
Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?49
Muscle memory: myonuclear accretion, maintenance, morphology, and miRNA levels with training and detraining in adult mice49
Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial48
Age‐related decline of interferon‐gamma responses in macrophage impairs satellite cell proliferation and regeneration47
Ketone Bodies Attenuate Wasting in Models of Atrophy47
Computed tomography‐defined low skeletal muscle index and density in cancer patients: observations from a systematic review47
0.19002914428711